4d
Zacks.com on MSNGILD vs. VRTX: Which Stock Is the Better Value Option?But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank with an ...
CeADAR, Ireland’s European Digital Hub for AI, which is hosted at University College Dublin (UCD), and Google signed the agreement at a meeting with the Minister for Enterprise, Tourism and Employment ...
In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...
Agentspace is a business-specific AI agent platform, which combines Gemini AI, Google search, and company data all in one ...
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...
AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...
“Mathemalchemy” has been described as “a mathematics fever dream turned artistic playground for all math lovers (and haters, ...
From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...
There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.
In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...
Google Cloud today announced new AI products, as well as initiatives and skills training for the United Kingdom at an exclusive "Gemini for the United Kingdom" event held at Google DeepMind's London ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results